Skip to search formSkip to main contentSkip to account menu

CD4-IgG(2)

Known as: CD4 IgG2, CD4-IgG2 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

CD4 Immunoadhesins

Narrower (1)

PRO-542

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Protection against High-Dose Highly Pathogenic Mucosal SIV Challenge at Very Low Serum Neutralizing Titers of the Antibody-Like Molecule CD4-IgG2
Passive transfer studies using monoclonal or polyclonal antibodies in the macaque model have been valuable for determining… 
2012
2012
Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization
Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced… 
2011
2011
SAXS data analysis and modeling of tetravalent neutralizing antibody CD4-IgG2 -/+ HIV-1 gp120 revealed that first two gp120 bind to the same Fab arm.
2004
2004
Formulations cd4-igg2 ameliorees
Cette invention porte sur des formulations de l'agent therapeutique contre le VIH, CD4-IgG2, qui contiennent des concentrations… 
2003
2003
A modified SCID mouse model of HIV infection with utility for testing anti-HIV therapies.
Using human tumor cells we have developed a mouse model of active HIV infection that may be used for testing antiviral agents… 
1996
1996
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer
Previous studies of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein-mediated membrane fusion have focused on… 
1992
1992
CHIMERES DE CD4-GAMMA1 ET DE CD4-IgG1
Cette invention decrit un vecteur d'expression codant un homodimere chimerique a chaine lourde de CD4-gamma1. L'invention se… 
1992
1992
Chimeras gamma2-CD4 and CD4-IgG2.
A chimeric heterotetramer IgG2-purified CD4 capable of neutralizing a virus HIV-1 infected with HIV-1 individual comprising two… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)